Eli Lilly and Co

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

A Study of LY4088044 in Healthy Participants

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity